rosuvastatinPapers
Papers about rosuvastatin
- papers
- 651
Newest first
451 to 500 of 651Every paper here, unless its row says otherwiseReturned by a PubMed search for rosuvastatin
Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).
The American journal of cardiology2010PMID 20599004
Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters.
Current medical research and opinion2010PMID 20731529
Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial for "intermediate risk".
Circulation. Cardiovascular quality and outcomes2010PMID 20736443
Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins.
Pharmacoepidemiology and drug safety2010PMID 20922707
Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial.
European journal of heart failure2010PMID 20952767
Efficacy and safety of rosuvastatin 5 mg in combination with fenofibric acid 135 mg in patients with mixed dyslipidemia - a phase 3 study.
Cardiovascular drugs and therapy2010PMID 20953684
Combination rosuvastatin plus fenofibric acid in a cohort of patients 65 years or older with mixed dyslipidemia: subanalysis of two randomized, controlled studies.
Clinical cardiology2010PMID 20960535
Impact of baseline plaque components on plaque progression in nonintervened coronary segments in patients with angina pectoris on rosuvastatin 10 mg/day.
The American journal of cardiology2010PMID 21029819
Ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency.
Lipids in health and disease2010PMID 21050476
Characteristics and drug utilization patterns of new users of rosuvastatin and other statins in four countries.
Minerva cardioangiologica2010PMID 21135803
Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients.
Journal of thrombosis and thrombolysis2009PMID 18636229
The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome.
International journal of cardiology2009PMID 18706705
ABT-335, the choline salt of fenofibric acid, does not have a clinically significant pharmacokinetic interaction with rosuvastatin in humans.
Journal of clinical pharmacology2009PMID 18952910
Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.
Atherosclerosis2009PMID 18996523
Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers.
Journal of lipid research2009PMID 19043140
Rationale and design of the carotid plaque in human for all evaluations with aggressive rosuvastatin therapy (CHALLENGER trial): evaluation by magnetic resonance imaging.
Circulation journal2009PMID 19057091
Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia.
Pharmaceutical research2009PMID 19082693
Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function.
Journal of cardiovascular pharmacology and therapeutics2009PMID 19158317
Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes.
Journal of lipid research2009PMID 19168444
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide.
European journal of heart failure2009PMID 19168876
Impact of a compliance program on cholesterol control: results of the randomized ORBITAL study in 8108 patients treated with rosuvastatin.
European journal of cardiovascular prevention and rehabilitation2009PMID 19174696
Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event.
The American journal of cardiology2009PMID 19195498
Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
International journal of clinical practice2009PMID 19222610
Rosuvastatin in hemodialysis: short-term effects on lipids and C-reactive protein.
Journal of nephrology2009PMID 19229822
Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia.
Journal of cardiovascular pharmacology and therapeutics2009PMID 19246334
Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study.
Diabetes care2009PMID 19265025
Effects of rosuvastatin and colestimide on metabolic parameters and urinary monocyte chemoattractant protein-1 in type 2 diabetic patients with hyperlipidemia.
Southern medical journal2009PMID 19279518
Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study.
Journal of the American College of Cardiology2009PMID 19281922
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
Lancet (London, England)2009PMID 19329177
A randomized trial of rosuvastatin in the prevention of venous thromboembolism.
The New England journal of medicine2009PMID 19329822
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.
The New England journal of medicine2009PMID 19332456
Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection.
Arteriosclerosis, thrombosis, and vascular biology2009PMID 19359665
Adding exercise training to rosuvastatin treatment: influence on serum lipids and biomarkers of muscle and liver damage.
Metabolism: clinical and experimental2009PMID 19411087
The effect of rosuvastatin on insulin sensitivity and pancreatic beta-cell function in nondiabetic renal transplant recipients.
American journal of transplantation2009PMID 19459810
Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?
Cardiovascular drugs and therapy2009PMID 19543962
Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.
Journal of internal medicine2009PMID 19549094
Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study).
The American journal of cardiology2009PMID 19576317
Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.
European heart journal2009PMID 19717850
Effects of rosuvastatin on low-density lipoprotein cholesterol and plasma lipids in Asian patients with hypercholesterolemia.
Journal of atherosclerosis and thrombosis2009PMID 19729865
A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial.
European journal of cardiovascular prevention and rehabilitation2009PMID 19745745
Effectiveness of rosuvastatin compared to other statins for the prevention of cardiovascular events-a cohort study in 395 039 patients from clinical practice.
Pharmacoepidemiology and drug safety2009PMID 19780020
Rosuvastatin does not affect intrarenal hemodynamics in patients with hypercholesterolemia.
Journal of nephrology2009PMID 19810001
Rosuvastatin increased serum osteocalcin levels independent of its serum cholesterol-lowering effect in patients with type 2 diabetes and hypercholesterolemia.
Internal medicine (Tokyo, Japan)2009PMID 19881236
Effect of simvastatin vs. rosuvastatin on adiponectin and haemoglobin A1c levels in patients with non-ischaemic chronic heart failure.
European journal of heart failure2009PMID 19889690
Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Journal of the American College of Cardiology2009PMID 19892235
Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
Circulation2009PMID 19917888
Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
Metabolic syndrome and related disorders2009PMID 19929597
Pharmacokinetics of rosuvastatin in patients with end-stage kidney disease undergoing peritoneal dialysis.
Clinical nephrology2009PMID 19954720
Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
Circulation. Cardiovascular quality and outcomes2009PMID 20031900
Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study.
Journal of the American College of Cardiology2009PMID 20082929